Literature DB >> 10444060

Prognostic factors in surgical treatment of solitary brain metastasis after resection of non-small-cell lung cancer.

Y Saitoh1, T Fujisawa, M Shiba, S Yoshida, Y Sekine, M Baba, T Iizasa, M Kubota.   

Abstract

Patients with brain metastasis after resection of non-small-cell lung cancer usually have poor prognosis. A few such patients, however, survive for long periods after surgical resection of brain metastases. To evaluate the prognostic factors in resection of solitary brain metastasis from non-small-cell lung cancer, we reviewed 24 cases undergoing resection of solitary brain metastasis after resection of the primary site from 1977 to 1993. The patient population consisted of 20 men and four women ranging in age from 40 to 75 years old (average, 57.8 years old). None of the patients had systemic metastasis except in the brain at the time of brain surgery. The overall survival rates were 12.5% at 3 years and 8.3% at 5 years after brain surgery. The longest survival periods were 11.5 years after brain surgery and 15.4 years after lung surgery. The interval between lung and brain surgery (< or =360 days vs. >360 days), differentiation of primary cancer (poor vs. moderate), size of primary site (< or =5.0 cm vs. >5.0 cm), and operation of primary site (lobectomy vs. pneumonectomy) significantly affected survival as shown by univariate analysis (P<0.05). Other clinical factors (age, gender, histology, T- and N-status, 'resectability with curative intent' of the primary site, location of the brain metastasis and postoperative radiation therapy) did not affect survival. Multivariate analysis using Cox's proportional hazards model indicated that an interval of more than 360 days between the two surgical procedures (hazard ratio = 0.2351, P = 0.0136) and lobectomy (hazard ratio = 0.5274, P = 0.0416) were independent prognostic factors. In conclusion, patients with solitary brain metastasis from non-small-cell lung cancer without other organ metastasis, in whom relapse in the brain occurred more than 1 year after resection of the primary site and in whom lobectomy was performed, should be treated surgically to maximize the chance of prolonged survival.

Entities:  

Mesh:

Year:  1999        PMID: 10444060     DOI: 10.1016/s0169-5002(99)00034-3

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  16 in total

Review 1.  Management of non-small cell lung cancer with oligometastasis.

Authors:  Liza C Villaruz; Gregory J Kubicek; Mark A Socinski
Journal:  Curr Oncol Rep       Date:  2012-08       Impact factor: 5.075

Review 2.  Surgical management of brain metastases.

Authors:  J S Weinberg; F F Lang; R Sawaya
Journal:  Curr Oncol Rep       Date:  2001-11       Impact factor: 5.075

Review 3.  Approach for oligometastasis in non-small cell lung cancer.

Authors:  Hidemi Suzuki; Ichiro Yoshino
Journal:  Gen Thorac Cardiovasc Surg       Date:  2016-02-19

Review 4.  Intracranial metastatic disease rarely involves the pituitary: retrospective analysis of 935 metastases in 155 patients and review of the literature.

Authors:  James C Marsh; Shalini Garg; Julie A Wendt; Benjamin T Gielda; Julius V Turian; Arnold M Herskovic
Journal:  Pituitary       Date:  2010-09       Impact factor: 4.107

Review 5.  Surgical resection for patients with solid brain metastases: current status.

Authors:  Peter M Black; Mark D Johnson
Journal:  J Neurooncol       Date:  2004 Aug-Sep       Impact factor: 4.130

6.  Surgical Management of Non-small Cell Lung Cancer with Solitary Hematogenous Metastases.

Authors:  Grigorios Karagkiouzis; Eleftherios Spartalis; Demetrios Moris; Demetrios Patsouras; Athanasios Athanasiou; Ioannis Karathanasis; Alexios Verveniotis; Froso Konstantinou; Ilias A Kouerinis; Konstantinos Potaris; Dimitrios Dimitroulis; Periklis Tomos
Journal:  In Vivo       Date:  2017 May-Jun       Impact factor: 2.155

Review 7.  Management of brain metastases: the indispensable role of surgery.

Authors:  George Al-Shamy; Raymond Sawaya
Journal:  J Neurooncol       Date:  2009-04-09       Impact factor: 4.130

8.  Recursive partitioning analysis classification and graded prognostic assessment for non-small cell lung cancer patients with brain metastasis: a retrospective cohort study.

Authors:  Cai-Xing Sun; Tao Li; Xiao Zheng; Ju-Fen Cai; Xu-Li Meng; Hong-Jian Yang; Zheng Wang
Journal:  Chin J Cancer Res       Date:  2011-09       Impact factor: 5.087

9.  Long-term survival without surgery in NSCLC patients with synchronous brain oligometastasis: systemic chemotherapy revisited.

Authors:  Jun Sato; Hidehito Horinouchi; Yasushi Goto; Shintaro Kanda; Yutaka Fujiwara; Hiroshi Nokihara; Noboru Yamamoto; Yuichiro Ohe
Journal:  J Thorac Dis       Date:  2018-03       Impact factor: 2.895

10.  Surgical Treatment in Small-Cell Lung Cancer: Single-Center Experience and Survival.

Authors:  Ahmet Ulusan; İbrahim Emre Tunca; Maruf Şanlı; Ahmet Feridun Işık
Journal:  Turk Thorac J       Date:  2021-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.